Surgical de-escalation in early-stage cervical cancer: current evidence and future perspectives

The surgical management of early-stage cervical cancer is undergoing a paradigm shift from a uniform radical approach to a risk-adapted de-escalation strategy. Improved oncologic outcomes have increased long-term survival, bringing attention to the importance of addressing treatment-related morbidity and quality of life. Emerging clinical evidence has challenged the necessity of extensive surgery in selected patients. This narrative review summarizes recent evidence supporting surgical de-escalation across three domains: uterine surgery, nodal management, and surgical approach. Studies were identified through a targeted narrative literature search and selected based on study design, oncologic outcomes, and methodological considerations. For uterine surgery, randomized trials demonstrate that omitting or reducing parametrial resection is oncologically safe for rigorously defined low-risk patients, yielding consistent improvements in postoperative functional outcomes. In nodal management, sentinel lymph node-based strategies allow the omission of systematic pelvic lymphadenectomy without compromising oncologic safety, when strict mapping algorithms and high-quality pathological assessment are applied. For surgical approach, however, de-escalation remains more controversial. Current evidence suggests that oncologic safety in minimally invasive surgery may depend on protocol-driven prevention of intraoperative tumor spillage and appropriate patient selection, but this approach remains investigational. Surgical de-escalation should not be viewed as merely reducing procedures. Rather, it represents a structured, evidence-based strategy incorporating risk stratification, standardized surgical techniques, and rigorous quality assurance. When these prerequisites are met, de-escalation optimally balances oncologic safety with quality-of-life preservation, potentially guiding future tailored surgical strategies for early-stage cervical cancer.